Skip to content

Effectiveness of Homoeopathic medicine in the management of Chronic Bronchitis

To Compare the effectiveness of individualised Homoeopathic medicine versus Senega mother tincture in management of Chronic Bronchitis-A Single Blind Randomised controlled trial - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068988
Enrollment
60
Registered
2024-06-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J40-J47- Chronic lower respiratory diseases

Interventions

Intervention1: Senega Mother Tincture: A complete detailed case taking and repertorisation will be done according to the homoeopathic principles and then allocated medicine will be given as per compu

Sponsors

Dr Vaishali Jangid
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having clinical signs and symptoms of chronic bronchitis. Pre diagnosed cases of Chronic bronchitis. Patients on conventional treatment for Chronic bronchitis. Patients giving informed consent. Patients willing to come for regular follow ups.

Exclusion criteria

Exclusion criteria: Patients suffering from chronic asthmatic bronchitis with restriction of activities. Patients with serious complications and other uncontrolled or life-threatening systemic illness. Patients having bronchiectasis or pulmonary phthisis. Diagnosed cases of psychiatric illness. Pregnant women and lactating mothers. Substance abuse/dependance. Patients who are not willing to be a part of this study. Self-reported immunocompromised state.

Design outcomes

Primary

MeasureTime frame
To evaluate which is more effective i.e., individualized homoeopathic medicine or Senega mother tincture in management of chronic bronchitis. To assess the improvement of patient in terms of frequency of attack and severity of symptoms of chronic bronchitis. Timepoint: Baseline, 4 weeks

Secondary

MeasureTime frame
To assess the improvement in symptomatology using mMRC dyspnoea score. To assess the health improvement using CAT questionnaireTimepoint: 2 weeks

Countries

India

Contacts

Public ContactDr Vaishali Jangid

Nehru Homoeopathic Medical College and Hospital

drgeorgem@gmail.com9868246297

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026